[Multiple autoimmune bullous dermatosis within a family].
A
A
Masmoudi
H
H
Cheikhrouhou
F
F
Frigui
O
O
Abida
M
M
Ben Ayed
N
N
Lehyani
M
M
Amouri
H
H
Masmoudi
H
H
Makni
A
A
Zahaf
H
H
Turki
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D005260:Female; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005938:Glucocorticoids / Q000627:therapeutic use; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D007223:Infant; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D011241:Prednisone / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D006680:HLA Antigens; D007070:Immunoglobulin A; D003622:Dapsone; D011241:Prednisone